国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Uncharacterized protein ykzT (ykzT) CSB-YP496582BRI
CSB-EP496582BRI
CSB-BP496582BRI
CSB-MP496582BRI
CSB-EP496582BRI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized membrane protein ynzK (ynzK), partial CSB-YP496583BRI1
CSB-EP496583BRI1
CSB-BP496583BRI1
CSB-MP496583BRI1
CSB-EP496583BRI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein yozY (yozY) CSB-YP496584BRI
CSB-EP496584BRI
CSB-BP496584BRI
CSB-MP496584BRI
CSB-EP496584BRI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein yoyH (yoyH) CSB-YP496585BRI
CSB-EP496585BRI
CSB-BP496585BRI
CSB-MP496585BRI
CSB-EP496585BRI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein ypzG (ypzG) CSB-YP496586BRI
CSB-EP496586BRI
CSB-BP496586BRI
CSB-MP496586BRI
CSB-EP496586BRI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized membrane protein yqzK (yqzK), partial CSB-YP496587BRI1
CSB-EP496587BRI1
CSB-BP496587BRI1
CSB-MP496587BRI1
CSB-EP496587BRI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized membrane protein yrzS (yrzS), partial CSB-YP496588BRI1
CSB-EP496588BRI1
CSB-BP496588BRI1
CSB-MP496588BRI1
CSB-EP496588BRI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum tRNA (guanine (37)-N1)-methyltransferase, partial CSB-YP496589EWP
CSB-EP496589EWP
CSB-BP496589EWP
CSB-MP496589EWP
CSB-EP496589EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmo salar Anamorsin-B (ciapin1-2) CSB-YP496590SWI
CSB-EP496590SWI
CSB-BP496590SWI
CSB-MP496590SWI
CSB-EP496590SWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pinctada fucata Prisilkin-39, partial CSB-YP496591EVV1
CSB-EP496591EVV1
CSB-BP496591EVV1
CSB-MP496591EVV1
CSB-EP496591EVV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles hirsuta Sphingomyelin phosphodiesterase D LhSicTox-alphaIA2av CSB-YP496592LQZ
CSB-EP496592LQZ
CSB-BP496592LQZ
CSB-MP496592LQZ
CSB-EP496592LQZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles hirsuta Sphingomyelin phosphodiesterase D LhSicTox-alphaIA2biv CSB-YP496593LQZ
CSB-EP496593LQZ
CSB-BP496593LQZ
CSB-MP496593LQZ
CSB-EP496593LQZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles hirsuta Sphingomyelin phosphodiesterase D LhSicTox-alphaIA1ii CSB-YP496594LQZ
CSB-EP496594LQZ
CSB-BP496594LQZ
CSB-MP496594LQZ
CSB-EP496594LQZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles arizonica Sphingomyelin phosphodiesterase D LarSicTox-alphaIB2bii CSB-YP496595LQW
CSB-EP496595LQW
CSB-BP496595LQW
CSB-MP496595LQW
CSB-EP496595LQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles arizonica Sphingomyelin phosphodiesterase D LarSicTox-alphaIB1aiii CSB-YP496596LQW
CSB-EP496596LQW
CSB-BP496596LQW
CSB-MP496596LQW
CSB-EP496596LQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles apachea Sphingomyelin phosphodiesterase D LapSicTox-alphaIB1c CSB-YP496597LQV
CSB-EP496597LQV
CSB-BP496597LQV
CSB-MP496597LQV
CSB-EP496597LQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles deserta Sphingomyelin phosphodiesterase D LdSicTox-alphaIB1bi CSB-YP496598LQY
CSB-EP496598LQY
CSB-BP496598LQY
CSB-MP496598LQY
CSB-EP496598LQY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles deserta Sphingomyelin phosphodiesterase D LdSicTox-alphaIB1avi CSB-YP496599LQY
CSB-EP496599LQY
CSB-BP496599LQY
CSB-MP496599LQY
CSB-EP496599LQY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles deserta Sphingomyelin phosphodiesterase D LdSicTox-alphaIB3avi CSB-YP496600LQY
CSB-EP496600LQY
CSB-BP496600LQY
CSB-MP496600LQY
CSB-EP496600LQY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles variegata Sphingomyelin phosphodiesterase D LvSicTox-alphaIC1aii CSB-YP496601LRH
CSB-EP496601LRH
CSB-BP496601LRH
CSB-MP496601LRH
CSB-EP496601LRH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>